Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, June 19, 2026
🇺🇸 FDA

lonvo-z News

🇺🇸 FDA ← All news

FDA lonvo-z coverage for business development, investment, and market access teams

Critical impact NewsApr 28, 2026

Intellia Therapeutics Submits FDA Application for Lonvo-Z, First CRISPR Gene Therapy for Hereditary Angioedema

FDA · Hereditary Angioedema · 3 min

Dr. Natalie Hughes
Critical impact NewsApr 28, 2026

Intellia Therapeutics Achieves First-Ever Positive Phase 3 Results for In Vivo Gene Editing with Lonvoguran Ziclumeran in Hereditary Angioedema

Hereditary Angioedema (HAE) · 3 min

James Chen, PharmD

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.